|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-3.16/-0.98
|
企业价值
42.69M
|
资产负债 |
每股账面净值
-0.42
|
现金流量 |
现金流量率
--
|
损益表 |
收益
3.13M
|
每股收益
0.14
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/17 23:52 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders. |